These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 600314)

  • 1. Effect of entekohepatic circulation on the pharmacokinetics of spironolactone in man.
    Abshagen U; von Grodzicki U; Hirschberger U; Rennekamp H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Nov; 300(3):281-7. PubMed ID: 600314
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of spironolactone, canrenone and canrenoate-K in humans.
    Sadée W; Dagcioglu M; Schröder R
    J Pharmacol Exp Ther; 1973 Jun; 185(3):686-95. PubMed ID: 4712657
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of spironolactone in man.
    Abshagen U; Rennekamp H; Luszpinski G
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):37-45. PubMed ID: 1012347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The importance of the biliary excretion of drugs in the human].
    Siegers CP; Klaassen CD
    Dtsch Med Wochenschr; 1983 Oct; 108(41):1564-70. PubMed ID: 6352227
    [No Abstract]   [Full Text] [Related]  

  • 5. Conversion of spironolactone to canrenone and disposition kinetics of spironolactone and canrenoate-potassium in rats.
    Sadée W; Abshagen U; Finn C; Rietbrock N
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(3):303-18. PubMed ID: 4276758
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple dose kinetics of spironolactone and canrenoate-potassium in cardiac and hepatic failure.
    Sadée W; Schröder R; von Leitner E; Dagcioglu M
    Eur J Clin Pharmacol; 1974; 7(3):195-200. PubMed ID: 4853286
    [No Abstract]   [Full Text] [Related]  

  • 7. New insights into the pharmacokinetics of spironolactone.
    Overdiek HW; Hermens WA; Merkus FW
    Clin Pharmacol Ther; 1985 Oct; 38(4):469-74. PubMed ID: 4042530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of tritium-labeled spirolactones in the dog.
    Sadée W; Riegelman S; Jones SC
    J Pharm Sci; 1972 Jul; 61(7):1132-5. PubMed ID: 5044816
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of pretreatment with spironolactone of pharmacokinetics of 4'''-methyldigoxin in man.
    Abshagen U; Rennekamp H; Kuhlmann J
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):87-92. PubMed ID: 934358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spironolactone. I. Disposition and metabolism.
    Karim A; Zagarella J; Hribar J; Dooley M
    Clin Pharmacol Ther; 1976 Feb; 19(2):158-69. PubMed ID: 1261153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aldadiene and other metabolites in the blood and urine after rectal appliacation of spironolactone and injection of aldaliene-potassium].
    Wagner H; Weist F; Zicha L
    Arzneimittelforschung; 1967 Apr; 17(4):415-9. PubMed ID: 5632434
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of a simple fluorometric 11-hydroxycorticosteroids assay in the assessment of spironolactone-metabolite level in plasma and urine.
    Radó JP; Szende L; Takó J; Nagy O
    Endokrinologie; 1974 Nov; 64(1):22-32. PubMed ID: 4466654
    [No Abstract]   [Full Text] [Related]  

  • 13. Biliary excretion and enterohepatic circulation of pregnanolone in the rat.
    Long RJ; Soyka LF
    Biochem Pharmacol; 1975 May; 24(10):1067-72. PubMed ID: 1156432
    [No Abstract]   [Full Text] [Related]  

  • 14. Spironolactone metabolism in man studied by gas chromatography-mass spectrometry.
    Karim A; Hribar J; Aksamit W; Doherty M; Chinn LJ
    Drug Metab Dispos; 1975; 3(6):467-78. PubMed ID: 1221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition kinetics of spironolactone in hepatic failure after single doses and prolonged treatment.
    Abshagen U; Rennekamp H; Luszpinski G
    Eur J Clin Pharmacol; 1977 Mar; 11(3):169-76. PubMed ID: 856602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enterohepatic circulation in liver diseases].
    Epping J; Fuchshofen M; Richter E
    Med Klin; 1980 Feb; 75(3):116-21. PubMed ID: 7374608
    [No Abstract]   [Full Text] [Related]  

  • 17. Spironolactone metabolism and gynaecomastia.
    Overdiek JW; Merkus FW
    Lancet; 1986 May; 1(8489):1103. PubMed ID: 2871374
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic analysis of concentration-time data obtained following administration of drugs that are recycled in the bile.
    Colburn WA
    J Pharm Sci; 1984 Mar; 73(3):313-7. PubMed ID: 6585546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterohepatic circulation of drugs.
    Dobrinska MR
    J Clin Pharmacol; 1989 Jul; 29(7):577-80. PubMed ID: 2760253
    [No Abstract]   [Full Text] [Related]  

  • 20. Absorption and enterohepatic circulation of baicalin in rats.
    Xing J; Chen X; Zhong D
    Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.